Market research
603538.SHG Ningbo Menovo Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 9B
- P/E ratio
- 66.24
- Analyst target
- 21.07
- Dividend yield
- 0.4%
- Beta
- -0.17
Community
Investor discussion
1 comment
Sign in to join the 603538.SHG discussion.
5 years, 5 months ago
Ningbo Menovo Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 19.9% above its 200 day moving average.
From a valuation standpoint, the stock is 59.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.9.
Ningbo Menovo Pharmaceutical Co., Ltd's total revenue rose by 2.4% to $297M since the same quarter in the previous year.
Its net income has dropped by 19.5% to $34M since the same quarter in the previous year.
Finally, its free cash flow grew by 130.4% to $29M since the same quarter in the previous year.
Based on the above factors, Ningbo Menovo Pharmaceutical Co., Ltd gets an overall score of 4/5.